Side-by-side comparison of AI visibility scores, market position, and capabilities
Cambridge MA neuroscience biopharma (NASDAQ: BIIB) at $9.7B 2024 revenue; LEQEMBI $87M Q4 (Alzheimer's first-in-class amyloid therapy), SKYCLARYS $102M Q4 (Friedreich's ataxia), MS franchise declining vs. Eli Lilly donanemab.
Biogen Inc. is a Cambridge, Massachusetts-based neuroscience biopharmaceutical company — publicly traded on NASDAQ (NASDAQ: BIIB) as an S&P 500 Health Care component — researching, developing, and commercializing therapies for neurological, neurodegenerative, and neurodevelopmental diseases including Alzheimer's disease, multiple sclerosis, spinal muscular atrophy, and rare neurological conditions through approximately 7,400 employees worldwide. In fiscal year 2024, Biogen reported total revenue of $9.7 billion (-2% year-over-year) and GAAP diluted EPS of $11.18 (+40%), reflecting significant cost-cutting that improved profitability despite modest revenue decline. Revenue decline was driven by continued erosion in the core multiple sclerosis franchise (TECFIDERA, AVONEX, TYSABRI facing generic and biosimilar competition) while new product revenue grew: LEQEMBI (lecanemab, Alzheimer's disease, partnered with Eisai) generated approximately $87 million in Q4 2024 global sales — reflecting the slow but building commercial trajectory of the first drug to slow Alzheimer's cognitive decline — and SKYCLARYS (omaveloxolone, Friedreich's ataxia) generated $102 million in Q4, nearly double the year-earlier period. CEO Christopher Viehbacher, who joined in 2022 from Genentech's parent Roche, has led a strategic restructuring that includes cost reduction, pipeline refocus on high-probability neurology programs, and the LEQEMBI commercial execution through a partnership model with Eisai.
Trimble (NASDAQ: TRMB) precision agriculture software with GPS guidance and variable rate application for farm management; competing with John Deere Operations Center and Climate FieldView for crop data platform.
Trimble Ag Software is the precision agriculture software division of Trimble Inc. (NASDAQ: TRMB) — a Sunnyvale, California-based positioning and workflow technology company with $3.7 billion in annual revenue — providing farmers, agronomists, and farm managers with field mapping, GPS-guided variable rate application, crop record management, and agronomic analytics that enable data-driven farming decisions across planting, spraying, harvesting, and soil management. Operating under the Trimble Agriculture brand with products including Trimble TMX-2050, Trimble Farmer Core/Pro/Premium, and the Trimble Connected Farm suite, the division serves large-scale crop producers and ag service providers in North America, Europe, and Australia.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.